Business Context and Reporting Period
This Form 8-K Current Report from Harvard Bioscience, Inc. (HBIO) covers the 2019 Annual Meeting of Stockholders held on May 16, 2019. The filing details the voting results for four proposals submitted to security holders.
Key Financial Metrics
This filing is a corporate governance report regarding stockholder votes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
There are no material financial changes reported in this document. The primary events are the successful election of directors, ratification of auditors, approval of an equity plan amendment, and advisory approval of executive compensation.
Guidance, Outlook, and Voting Results
Management commentary and financial guidance are not included in this filing. The following voting outcomes were reported:
- Proposal 1 (Election of Directors): James W. Green and Bertrand Loy were elected as Class I Directors for three-year terms.
- James W. Green: 22,806,995 votes for; 8,033,336 votes withheld.
- Bertrand Loy: 21,644,267 votes for; 9,196,064 votes withheld.
- Proposal 2 (Ratification of Auditors): Grant Thornton LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- 35,340,119 votes for; 71,129 votes against; 16,689 abstained.
- Proposal 3 (ESPP Amendment): Stockholders approved an amendment to the Employee Stock Purchase Plan to increase authorized shares by 350,000.
- 25,617,444 votes for; 5,160,104 votes against; 62,783 abstained.
- Proposal 4 (Executive Compensation): The compensation of named executive officers was approved via a non-binding advisory vote.
- 30,327,475 votes for; 428,343 votes against; 84,513 abstained.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the specific terms of the Employee Stock Purchase Plan amendment approved in Proposal 3.
- Confirm the tenure and background of the newly elected Class I Directors, James W. Green and Bertrand Loy.
- Check subsequent filings for the company's fiscal year-end financial results, as this 8-K contains no financial data.